BCI
GHDX

Brinker Capital Investments’s Genomic Health, Inc. GHDX Stock Holding History

Brinker Capital Investments’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-40
Closed -$2K – 1000
2019
Q2 		$2K Hold
40
– – ﹤0.01% 896
2019
Q1 		$3K Buy
+40
New +$2.97K ﹤0.01% 771

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Brinker Capital Investments's GHDX Position: Q3 2019 in Review

Brinker Capital Investments sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 40 shares — an estimated $2K sold.

Brinker Capital Investments first reported a position in GHDX in Q1 2019 and held it in 2 quarters. The position peaked at $3K in Q1 2019. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Brinker Capital Investments reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Brinker Capital Investments sold 40 Genomic Health, Inc. shares in Q3 2019, an estimated $2K.
  • Brinker Capital Investments first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 2 quarters.
  • Brinker Capital Investments's Genomic Health, Inc. position peaked at $3K in Q1 2019.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Brinker Capital Investments's 13F filing for Q3 2019, filed 14 Nov 2019.